查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463021

臨床試驗影像市場,佔有率,規模,趨勢,產業分析報告:依產品,模式,應用,最終用戶,地區,細分市場進行預測2024-2032 年

Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球臨床試驗影像市場規模預計將達到2,2501.2億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

臨床試驗成像市場是由全球慢性病的流行所推動的。心血管疾病、癌症和神經系統疾病等疾病呈現上升趨勢，開發治療方法的努力也不斷增加。臨床試驗影像利用 MRI、CT、PET 和超音波等方式，在評估疾病進展、治療反應和患者結果方面發揮著至關重要的作用。隨著進行更大規模、更複雜的臨床試驗來評估新療法，影像終點提供了治療效果的客觀指標。監管機構要求藥物審批提供可靠的影像數據，進一步推動對臨床試驗影像服務的需求。

臨床試驗成像市場也受到成像生物標記應用不斷擴大的推動。這些生物標記提供生物過程和治療反應的定量測量，可用於各個治療領域的疾病監測和治療評估。它們在精準醫療和個人化治療中發揮關鍵作用，能夠實現有針對性的干預並改善治療結果。成像技術和分析方法的進步擴大了可用於臨床的成像生物標記的範圍。此外，人工智慧 (AI) 和機器學習演算法的整合正在增強生物標記分析、簡化數據處理並提高臨床試驗的可重複性。

人工智慧（AI）技術的整合為臨床試驗成像市場帶來了重大機會。機器學習和深度學習模型等人工智慧演算法透過自動化任務、減少錯誤和加快數據處理速度，正在徹底改變醫學影像分析。在臨床試驗中，人工智慧驅動的影像分析透過快速識別影像生物標記的細微變化來提高效率，促進早期治療反應檢測。此外，基於人工智慧的解決方案可以從大型影像資料集中獲得有價值的見解，以幫助患者分層和治療選擇。其可擴展性和適應性簡化了臨床試驗操作並促進利害關係人之間的協作。

結合不同的成像模式（例如 MRI、PET、CT 和光學成像）可為研究人員提供補充訊息，從而提高診斷準確性和治療評估。多模態成像克服了單一模態的局限性，提供了對疾病病理學和治療效果的全面瞭解。結合多個成像參數也將促進新型成像生物標記的開發，從而更深入地瞭解疾病進展和治療效果。此外，影像配準、融合技術和人工智慧演算法的進步將簡化數據分析並促進臨床試驗設計和實施的創新。

臨床試驗成像市場報告亮點

2023年，由於其在整個臨床試驗過程中的不可或缺的作用、靈活性和可擴展性以及成本效益，操作成像服務行業佔據了重要的收入佔有率。

2023年，電腦斷層掃瞄領域因其診斷多功能性、應用範圍廣泛和影像擷取快速而佔據了很大的收入佔有率。

2023年，由於腫瘤臨床試驗的高發生率、腫瘤臨床試驗的複雜性以及腫瘤藥物管線的不斷增加，腫瘤領域佔據了重要的收入佔有率。

由於藥物開發措施、精準醫學的進步和治療創新，製藥和生技公司的需求預計在預測期內將會增加。

2023年，北美地區由於先進的醫療基礎設施、大量的臨床試驗以及大型製藥公司的存在，佔據了主要的市場佔有率。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球臨床試驗影像市場洞察

  • 臨床試驗成像 - 產業快照
  • 臨床試驗成像市場動態
    • 驅動因素和機遇
      • 臨床試驗活動的增加預計將推動對該產品的需求。
      • 成像技術的進步預計將推動臨床試驗成像市場的成長
    • 限制因素和課題
      • 診斷影像服務的高成本可能會阻礙市場成長
  • PESTLE分析
  • 臨床試驗成像產業的趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第 5 章 全球市場（依產品劃分）

  • 主要發現
  • 介紹
  • 臨床試驗設計與諮詢服務
  • 營運影像服務
  • 專案和資料管理
  • 閱讀與分析服務
  • 系統和技術支援服務
  • 其他

第六章依形態劃分的全球市場

  • 主要發現
  • 介紹
  • 超聲波
  • CT檢查
  • X光
  • 磁共振成像
  • 其他

第七章依應用劃分的世界市場

  • 主要發現
  • 介紹
  • 神經病學
  • 腫瘤學
  • 感染
  • 內分泌學
  • 眼科
  • 心血管疾病
  • 其他

第八章最終用戶的全球市場

  • 主要發現
  • 介紹
  • 製藥和生物技術公司
  • 合約調查機構
  • 醫療器械製造商
  • 學術和政府研究機構
  • 其他

第 9 章依地區劃分的世界市場

  • 主要發現
  • 介紹
    • 臨床試驗影像市場評估（依地區），2019-2032
  • 臨床試驗影像市場 - 北美
    • 北美：2019-2032 年臨床試驗影像市場（依產品劃分）
    • 北美：臨床試驗成像市場，依最終用戶劃分，2019-2032 年
    • 北美：臨床試驗影像市場（依模式），2019-2032 年
    • 北美：臨床試驗影像市場，依應用分類，2019-2032
    • 臨床試驗影像市場—美國
    • 臨床試驗影像市場 - 加拿大
  • 臨床試驗影像市場 - 歐洲
    • 歐洲：臨床試驗影像市場（依產品劃分），2019-2032 年
    • 歐洲：臨床試驗影像市場，依最終使用者劃分，2019-2032 年
    • 歐洲：臨床試驗影像市場（依模式），2019-2032 年
    • 歐洲：臨床試驗影像市場，依應用分類，2019-2032
    • 臨床試驗影像市場—英國
    • 臨床試驗影像市場—法國
    • 臨床試驗影像市場—德國
    • 臨床試驗影像市場—義大利
    • 臨床試驗影像市場—西班牙
    • 臨床試驗影像市場—荷蘭
    • 臨床試驗影像市場—俄羅斯
  • 臨床試驗影像市場 - 亞太地區
    • 亞太地區：臨床試驗影像市場（依產品分類），2019-2032 年
    • 亞太地區：臨床試驗影像市場，依最終使用者劃分，2019-2032 年
    • 亞太地區：臨床試驗影像市場（依模式），2019-2032 年
    • 亞太地區：臨床試驗影像市場，依應用劃分，2019-2032 年
    • 臨床試驗影像市場 - 中國
    • 臨床試驗影像市場—印度
    • 臨床試驗影像市場 - 日本
    • 臨床試驗影像市場—馬來西亞
    • 臨床試驗影像市場—印度尼西亞
    • 臨床試驗影像市場—韓國
  • 臨床試驗影像市場—中東和非洲
    • 中東和非洲：臨床試驗影像市場（依產品分類），2019-2032 年
    • 中東和非洲：臨床試驗影像市場，依最終用戶劃分，2019-2032 年
    • 中東和非洲：臨床試驗影像市場（依模式），2019-2032 年
    • 中東和非洲：臨床試驗影像市場，依應用分類，2019-2032
    • 臨床試驗影像市場—沙烏地阿拉伯
    • 臨床試驗影像市場—南非
    • 臨床試驗影像市場—以色列
    • 臨床試驗影像市場 - 阿聯酋
  • 臨床試驗影像市場—拉丁美洲
    • 拉丁美洲：臨床試驗影像市場（依產品分類），2019-2032 年
    • 拉丁美洲：臨床試驗成像市場，依最終用戶劃分，2019-2032 年
    • 拉丁美洲：臨床試驗影像市場（依模式），2019-2032 年
    • 拉丁美洲：臨床試驗影像市場，依應用劃分，2019-2032 年
    • 臨床試驗影像市場—墨西哥
    • 臨床試驗影像市場 - 巴西
    • 臨床試驗影像市場—阿根廷

第10章競爭格局

  • 擴張和收購分析
    • 擴張
    • 獲得
  • 夥伴關係/協作/協議/出版物

第十一章公司簡介

  • BioClinica
  • Biomedical Systems Corp
  • BioTelemetry, Inc.
  • Cardiovascular Imaging Technologies
  • ICON plc
  • Intrinsic Imaging
  • IXICO plc
  • Median Technologies
  • Medpace
  • Merge Healthcare
  • Navitas Clinical Research, Inc
  • ProScan Imaging
  • Radiant Sage LLC
  • Resonance Health
  • WorldCare Clinical
Product Code: PM4696

The global clinical trial imaging market size is expected to reach USD 2,250.12 Million by 2032, according to a new study by Polaris Market Research. The report "Clinical Trial Imaging Market Share, Size, Trends, Industry Analysis Report, By Offering; By Modality (Ultrasound, Computed Tomography, X-Ray, Magnetic Resonance Imaging, Others); By Application; By End User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The clinical trial imaging market is propelled by the escalating prevalence of chronic diseases globally. Conditions like cardiovascular diseases, cancer, and neurological disorders are increasing, prompting heightened efforts in therapy development. Clinical trial imaging, utilizing modalities such as MRI, CT, PET, and ultrasound, plays a pivotal role in evaluating disease progression, treatment response, and patient outcomes. With larger and more intricate trials conducted to assess new interventions, imaging endpoints provide objective measures of treatment effects. Regulatory agencies mandate robust imaging data for drug approval, further boosting the demand for clinical trial imaging services.

The clinical trial imaging market is also experiencing growth driven by the expanding applications of imaging biomarkers. These biomarkers offer quantitative measurements of biological processes or treatment responses, aiding in disease monitoring and treatment evaluation across various therapeutic areas. They play a crucial role in precision medicine and personalized therapies, enabling targeted interventions and improving therapeutic outcomes. Advancements in imaging technologies and analytical methods have broadened the range of imaging biomarkers available for clinical use. Additionally, the integration of artificial intelligence (AI) and machine learning algorithms has enhanced biomarker analysis, streamlining data processing and improving reproducibility in clinical trials.

The integration of artificial intelligence (AI) technologies presents significant opportunities in the clinical trial imaging market. AI algorithms, such as machine learning and deep learning models, revolutionize medical image analysis by automating tasks, reducing errors, and expediting data processing. In clinical trials, AI-driven imaging analysis enhances efficiency by rapidly identifying subtle changes in imaging biomarkers, facilitating early treatment response detection. Moreover, AI-based solutions unlock valuable insights from large-scale imaging datasets, aiding in patient stratification and treatment selection. Their scalability and adaptability streamline trial operations, fostering collaboration among stakeholders.

By combining different imaging modalities like MRI, PET, CT, and optical imaging, researchers obtain complementary information, improving diagnostic accuracy and treatment assessment. Multi-modal imaging offers a comprehensive understanding of disease pathology and treatment effects, overcoming the limitations of individual modalities. It facilitates the development of novel imaging biomarkers by combining multiple imaging parameters, enhancing insights into disease progression and treatment response. Furthermore, advancements in image registration, fusion techniques, and AI algorithms streamline data analysis, driving innovation in clinical trial design and execution.

Clinical Trial Imaging Market Report Highlights

In 2023, the operational imaging services segment held considerable revenue share owing to its essential role in entire clinical trial process, flexibility and scalability, and cost-effectiveness.

In 2023, the computed tomography segment held significant revenue share owing to diagnostic versatility, wide application spectrum, and rapid imaging acquisition.

In 2023, the oncology segment held significant revenue share owing to high incidence of oncology trials, complexity of oncology trials, and growing pipeline of oncology drugs.

The demand from pharmaceutical & biotechnology companies is expected to increase during the forecast period owing to drug development initiatives, precision medicine advancements, and therapeutic innovation.

In 2023, North America region accounted for a significant market share due to advanced healthcare infrastructure, high volume of clinical trials, and presence of leading pharmaceutical companies.

The market is highly competitive owing to the existence of market players with a global presence, including BioClinica, BioTelemetry, Inc., Cardiovascular Imaging Technologies, ICON plc, Merge Healthcare, Navitas Clinical Research, Inc, Resonance Health, and WorldCare Clinical among others.

Polaris Market Research has segmented the Clinical Trial Imaging market report based on offering, modality, application, end user, and region:

Clinical Trial Imaging, Offering Outlook (Revenue - USD Million, 2019 - 2032)

  • Clinical Trial Design and Consultation Services
  • Operational Imaging Services
  • Project and Data Management
  • Reading and Analytical Services
  • System and Technology Support Services
  • Others

Clinical Trial Imaging, Modality Outlook (Revenue - USD Million, 2019 - 2032)

  • Ultrasound
  • Computed Tomography
  • X-Ray
  • Magnetic Resonance Imaging
  • Others

Clinical Trial Imaging, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Neurology
  • Oncology
  • Infectious Diseases
  • Endocrinology
  • Ophthalmology
  • Cardiovascular Diseases
  • Others

Clinical Trial Imaging, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Medical Device Manufacturers
  • Academic and Government Research Institutes
  • Others

Clinical Trial Imaging, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Clinical Trial Imaging Market Insights

  • 4.1. Clinical Trial Imaging - Industry Snapshot
  • 4.2. Clinical Trial Imaging Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing clinical trial activities are projected to spur the product demand
      • 4.2.1.2. Advancement in imaging technologies is expected to drive clinical trial imaging market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of imaging services is likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Clinical Trial Imaging Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Clinical Trial Imaging Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • 5.3. Clinical Trial Design and Consultation Services
    • 5.3.1. Global Clinical Trial Imaging Market, by Clinical Trial Design and Consultation Services, by Region, 2019-2032 (USD Million)
  • 5.4. Operational Imaging Services
    • 5.4.1. Global Clinical Trial Imaging Market, by Operational Imaging Services, by Region, 2019-2032 (USD Million)
  • 5.5. Project and Data Management
    • 5.5.1. Global Clinical Trial Imaging Market, by Project and Data Management, by Region, 2019-2032 (USD Million)
  • 5.6. Reading and Analytical Services
    • 5.6.1. Global Clinical Trial Imaging Market, by Reading and Analytical Services, by Region, 2019-2032 (USD Million)
  • 5.7. System and Technology Support Services
    • 5.7.1. Global Clinical Trial Imaging Market, by System and Technology Support Services, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Clinical Trial Imaging Market, by Modality

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • 6.3. Ultrasound
    • 6.3.1. Global Clinical Trial Imaging Market, by Ultrasound, by Region, 2019-2032 (USD Million)
  • 6.4. Computed Tomography
    • 6.4.1. Global Clinical Trial Imaging Market, by Computed Tomography, by Region, 2019-2032 (USD Million)
  • 6.5. X-Ray
    • 6.5.1. Global Clinical Trial Imaging Market, by X-Ray, by Region, 2019-2032 (USD Million)
  • 6.6. Magnetic Resonance Imaging
    • 6.6.1. Global Clinical Trial Imaging Market, by Magnetic Resonance Imaging, by Region, 2019-2032 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Clinical Trial Imaging Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 7.3. Neurology
    • 7.3.1. Global Clinical Trial Imaging Market, by Neurology, by Region, 2019-2032 (USD Million)
  • 7.4. Oncology
    • 7.4.1. Global Clinical Trial Imaging Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Global Clinical Trial Imaging Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
  • 7.6. Endocrinology
    • 7.6.1. Global Clinical Trial Imaging Market, by Endocrinology, by Region, 2019-2032 (USD Million)
  • 7.7. Ophthalmology
    • 7.7.1. Global Clinical Trial Imaging Market, by Ophthalmology, by Region, 2019-2032 (USD Million)
  • 7.8. Cardiovascular Diseases
    • 7.8.1. Global Clinical Trial Imaging Market, by Cardiovascular Diseases, by Region, 2019-2032 (USD Million)
  • 7.9. Others
    • 7.9.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

8. Global Clinical Trial Imaging Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Clinical Trial Imaging Market, by Pharmaceutical & Biotechnology Companies, by Region, 2019-2032 (USD Million)
  • 8.4. Contract Research Organizations
    • 8.4.1. Global Clinical Trial Imaging Market, by Contract Research Organizations, by Region, 2019-2032 (USD Million)
  • 8.5. Medical Device Manufacturers
    • 8.5.1. Global Clinical Trial Imaging Market, by Medical Device Manufacturers, by Region, 2019-2032 (USD Million)
  • 8.6. Academic and Government Research Institutes
    • 8.6.1. Global Clinical Trial Imaging Market, by Academic and Government Research Institutes, by Region, 2019-2032 (USD Million)
  • 8.7. Others
    • 8.7.1. Global Clinical Trial Imaging Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Clinical Trial Imaging Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Clinical Trial Imaging Market Assessment, By Geography, 2019-2032 (USD Million)
  • 9.3. Clinical Trial Imaging Market - North America
    • 9.3.1. North America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.3.2. North America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.3.3. North America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.3.4. North America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.3.5. Clinical Trial Imaging Market - U.S.
      • 9.3.5.1. U.S.: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.3.5.2. U.S.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.3.5.3. U.S.: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.3.5.4. U.S.: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.3.6. Clinical Trial Imaging Market - Canada
      • 9.3.6.1. Canada: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.3.6.2. Canada: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.3.6.3. Canada: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.3.6.4. Canada: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.4. Clinical Trial Imaging Market - Europe
    • 9.4.1. Europe: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.4.2. Europe: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.4.3. Europe: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.4.4. Europe: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.5. Clinical Trial Imaging Market - UK
      • 9.4.5.1. UK: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.5.2. UK: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.5.3. UK: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.5.4. UK: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.6. Clinical Trial Imaging Market - France
      • 9.4.6.1. France: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.6.2. France: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.6.3. France: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.6.4. France: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.7. Clinical Trial Imaging Market - Germany
      • 9.4.7.1. Germany: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.7.2. Germany: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.7.3. Germany: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.7.4. Germany: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.8. Clinical Trial Imaging Market - Italy
      • 9.4.8.1. Italy: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.8.2. Italy: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.8.3. Italy: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.8.4. Italy: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.9. Clinical Trial Imaging Market - Spain
      • 9.4.9.1. Spain: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.9.2. Spain: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.9.3. Spain: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.9.4. Spain: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.10. Clinical Trial Imaging Market - Netherlands
      • 9.4.10.1. Netherlands: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.10.2. Netherlands: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.10.3. Netherlands: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.10.4. Netherlands: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.4.11. Clinical Trial Imaging Market - Russia
      • 9.4.11.1. Russia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.4.11.2. Russia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.4.11.3. Russia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.4.11.4. Russia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.5. Clinical Trial Imaging Market - Asia Pacific
    • 9.5.1. Asia Pacific: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.5.2. Asia Pacific: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.5.3. Asia Pacific: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.5.4. Asia Pacific: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.5. Clinical Trial Imaging Market - China
      • 9.5.5.1. China: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.5.2. China.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.5.3. China: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.5.4. China: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.6. Clinical Trial Imaging Market - India
      • 9.5.6.1. India: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.6.2. India.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.6.3. India: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.6.4. India: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.7. Clinical Trial Imaging Market - Japan
      • 9.5.7.1. Japan: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.7.2. Japan.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.7.3. Japan: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.7.4. Japan: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.8. Clinical Trial Imaging Market - Malaysia
      • 9.5.8.1. Malaysia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.8.2. Malaysia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.8.3. Malaysia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.8.4. Malaysia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.9. Clinical Trial Imaging Market - Indonesia
      • 9.5.9.1. Indonesia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.9.2. Indonesia.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.9.3. Indonesia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.9.4. Indonesia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.5.10. Clinical Trial Imaging Market - South Korea
      • 9.5.10.1. South Korea: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.5.10.2. South Korea.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.5.10.3. South Korea: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.5.10.4. South Korea: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.6. Clinical Trial Imaging Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.6.2. Middle East & Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.6.3. Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.6.4. Middle East & Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.5. Clinical Trial Imaging Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.5.2. Saudi Arabia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.5.3. Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.5.4. Saudi Arabia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.6. Clinical Trial Imaging Market - South Africa
      • 9.6.6.1. South Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.6.2. South Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.6.3. South Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.6.4. South Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.7. Clinical Trial Imaging Market - Israel
      • 9.6.7.1. Israel: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.7.2. Israel: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.7.3. Israel: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.7.4. Israel: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.6.8. Clinical Trial Imaging Market - UAE
      • 9.6.8.1. UAE: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.6.8.2. UAE: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.6.8.3. UAE: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.6.8.4. UAE: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • 9.7. Clinical Trial Imaging Market - Latin America
    • 9.7.1. Latin America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
    • 9.7.2. Latin America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
    • 9.7.3. Latin America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
    • 9.7.4. Latin America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.5. Clinical Trial Imaging Market - Mexico
      • 9.7.5.1. Mexico: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.5.2. Mexico: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.5.3. Mexico: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.5.4. Mexico: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.6. Clinical Trial Imaging Market - Brazil
      • 9.7.6.1. Brazil: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.6.2. Brazil: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.6.3. Brazil: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.6.4. Brazil: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
    • 9.7.7. Clinical Trial Imaging Market - Argentina
      • 9.7.7.1. Argentina: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
      • 9.7.7.2. Argentina: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
      • 9.7.7.3. Argentina: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
      • 9.7.7.4. Argentina: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. BioClinica
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Biomedical Systems Corp
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. BioTelemetry, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Cardiovascular Imaging Technologies
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. ICON plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Intrinsic Imaging
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. IXICO plc
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Median Technologies
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Medpace
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merge Healthcare
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Navitas Clinical Research, Inc
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. ProScan Imaging
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Radiant Sage LLC
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Resonance Health
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. WorldCare Clinical
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables

  • Table 1 Global Clinical Trial Imaging Market, by Offering, by Region, 2019-2032 (USD Million)
  • Table 2 Global Clinical Trial Imaging Market, by Modality, by Region, 2019-2032 (USD Million)
  • Table 3 Global Clinical Trial Imaging Market, by Application, by Region, 2019-2032 (USD Million)
  • Table 4 Global Clinical Trial Imaging Market, by End User, by Region, 2019-2032 (USD Million)
  • Table 5 Clinical Trial Imaging Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 6 North America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 7 North America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 8 North America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 9 North America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 10 U.S.: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 11 U.S.: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 12 U.S.: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 13 U.S.: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 14 Canada: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 15 Canada: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 16 Canada: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 17 Canada: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 18 Europe: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 19 Europe: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 20 Europe: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 21 Europe: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 22 Germany: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 23 Germany: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 24 Germany: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 26 France: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 27 France: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 28 France: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 29 France: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 30 UK: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 31 UK: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 32 UK: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 33 UK: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 34 Italy: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 35 Italy: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 36 Italy: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 37 Italy: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 38 Netherlands: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 39 Netherlands: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 40 Netherlands: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 41 Netherlands: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 42 Spain: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 43 Spain: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 44 Spain: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 45 Spain: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 46 Russia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 47 Russia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 48 Russia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 49 Russia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 50 Asia Pacific: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 51 Asia Pacific: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 52 Asia Pacific: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 53 Asia Pacific: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 54 China: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 55 China: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 56 China: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 57 China: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 58 Japan: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 59 Japan: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 60 Japan: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 61 Japan: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 62 India: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 63 India: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 64 India: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 65 India: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 66 Indonesia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 67 Indonesia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 68 Indonesia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 69 Indonesia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 70 Malaysia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 71 Malaysia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 72 Malaysia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 73 Malaysia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 74 South Korea: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 75 South Korea: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 76 South Korea: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 77 South Korea: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 78 Latin America: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 79 Latin America: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 80 Latin America: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 81 Latin America: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 82 Brazil: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 83 Brazil: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 84 Brazil: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 85 Brazil: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 86 Mexico: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 87 Mexico: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 88 Mexico: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 89 Mexico: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 90 Argentina: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 91 Argentina: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 92 Argentina: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 93 Argentina: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 94 Middle East & Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 95 Middle East & Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 96 Middle East & Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 97 Middle East & Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 98 UAE: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 99 UAE: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 100 UAE: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 101 UAE: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 102 Saudi Arabia: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 103 Saudi Arabia: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 104 Saudi Arabia: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 105 Saudi Arabia: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 106 South Africa: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 107 South Africa: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 108 South Africa: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 109 South Africa: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)
  • Table 110 Israel: Clinical Trial Imaging Market, by Offering, 2019-2032 (USD Million)
  • Table 111 Israel: Clinical Trial Imaging Market, by Modality, 2019-2032 (USD Million)
  • Table 112 Israel: Clinical Trial Imaging Market, by Application, 2019-2032 (USD Million)
  • Table 113 Israel: Clinical Trial Imaging Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Clinical Trial Imaging Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up End User
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global Clinical Trial Imaging Market, by Offering, 2021 & 2030 (USD Million)
  • Figure 8. Market by End User
  • Figure 9. Global Clinical Trial Imaging Market, by End User, 2021 & 2030 (USD Million)
  • Figure 10. Market by Modality
  • Figure 11. Global Clinical Trial Imaging Market, by Modality, 2021 & 2030 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global Clinical Trial Imaging Market, by Application, 2021 & 2030 (USD Million)